Skip to content
references-2

REFERENCES

Akinbami, L. J. et al. (2011). Attention deficit hyperactivity disorder among children aged 5-17 years in the United States, 1998-2009. NCHS Data Brief. No. 70

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. Washington: American Psychiatric Association, 2000.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Arlington, VA: American Psychiatric Association, 2013.

Arnold, G.L., et al. (2003). Plasma amino acids profiles in children with autism: potential risk of nutritional deficiencies. Journal of autism and developmental disorders. 33(4): p. 449-454.

Baker, M.G., Graham L. (2004). The journey: Parkinson’s disease. BMJ. 329 (7466): 611-614.

Bronte-Stewart, H.M., Minn, A. Y., et al. (2002). Postural instability in idiopathic Parkinson’s disease: the role of medication and unilateral pallidotomy. Guarantors of Brain. 125:2100-2114.

Cakit, B. D. (2007). The effects of incremental speed-dependent treadmill training on postural instability and fear of falling in Parkinson’s disease. Clinical Rehabilitation. 21:698-705

Christensen, D.L., et al. (2016). Prevalence and Characteristics of Autism Spectrum Disorder Among 4-Year-Old Children in the Autism and Developmental Disabilities Monitoring Network. Journal of Developmental & Behavioral Pediatrics. 37(1): p. 1-8.

de Lau, L.M. and M.M. Breteler (2006). Epidemiology of Parkinson’s disease. The Lancet Neurology. 5(6): p. 525-535.

Datamonitor ASD Epidemiology 2011, Child and Adolescent Psychiatric Clinics 2003, Booz & Company.

Dorsey, E.R. et al. (2007). Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology.

Edwards, L.L., et al. (1991). Gastrointestinal symptoms in Parkinson’s disease. Movement Disorders. 6(2): 151-156.

Evans, C., et al. (2008). Altered amino acid excretion in children with autism. Nutritional neuroscience. 11(1): p. 9-17.

Fafournoux, P., A. Bruhat, and C. Jousse (2000). Amino acid regulation of gene expression. Biochem J. 351(Pt 1): p. 1-12.

Global Industry Analysts. ADHD therapeutics – a global strategic business report. 2010.

Heetun, Z. Quigley, E. (2012). Gastroparesis and Parkinson’s disease: a systematic review. Parkinsonism and Related Disorders. 18: 443-440.

Krasner, N., et al. (1976). Alcohol and absorption from the small intestine. 1. Impairment of absorption from the small intestine in alcoholics. Gut. 17(4): p. 245-248.

Lo Bianco, C., Schneider, B.L., et al. (2004). Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an SYMBOL-synuclein rat model of Parkinson’s disease. Proceedings of the National Academy of Sciences. Vol. 101(50): 17510-17515.

Mezey, E., et al. (1970). Pancreatic function and intestinal absorption in chronic alcoholism. Gastroenterology. 59: p. 657-664.

National Institute for Mental Health (2012). ADHD. http://www.nimh.nih.gov/health/publications/attention-deficit-hyperactivity-disorder/index.shtml

National Parkinson Foundation (2013). How is PD treated? www.parkinson.org/Parkinson-s-Disease/Treatment

Parkinson’s Disease Foundation (2016). http://www.pdf.org/en/parkinson_statistics

Perrotti, L., et al. (2008). Distinct patterns of ΔFosB induction in brain by drugs of abuse. Synapse. 62(5): p. 358-369.

Pfeiffer, R. (2007). Gastrointestinal and urinary function in PD. Parkinson’s Disease Foundation: Understanding Parkinson’s. http://www.pdf.org/en/spring07_gastrointestinal_and_urinary_dysfunction_in_pd

Pfeiffer, R. (2010). Gastrointestinal urological, and sexual dysfunction in Parkinson’s disease. Movement Disorders. Vol. 25: S94-S97

Regier, D.A., et al. (1993). The de facto US mental and addictive disorders service system: Epidemiologic Catchment Area prospective 1-year prevalence rates of disorders and services. Archives of general psychiatry. 50(2): p. 85-94.

Simonoff, E. et al. (2008). Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. Journal of American Academy of Child Adolescent Psychiatry. 47(8) 921-929.

Thomas, R., Sanders, S., Doust, J., Beller, E., & Glasziou, P. (2015). Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Pediatrics, 135(4), 994-1001.

Visser, S.N., et al. (2014). Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003–2011. Journal of the American Academy of Child & Adolescent Psychiatry. 53(1): p. 34-46. e2. 

Wilens, T. et al. (2002). Attention deficit/hyperactivity disorder across the lifespan. Annual Review of Medicine. 53: 113-131

Wood, B.H., Bilclough, J.A., Bowron, A., Walker, R.W. (2002). Incidence and prediction of falls in Parkinson’s disease: a prospective multidisciplinary study. Journal of Neurology and Neurosurgery Psychiatry. 72: 721-725

Zhang, Y., et al. (2007). Differential effects of phenylalanine on Rac1, Cdc42, and RhoA expression and activity in cultured cortical neurons. Pediatric research. 62(1): p. 8-13.